Research and Markets: Despite Global Efforts to Stop Smoking, Incidence Rates of Non-Small Cell Lung Cancer Will Remain Unchanged

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/ea4043/epidemiology_non) has announced the addition of the "Epidemiology: Non-Small Cell Lung Cancer - Despite global efforts to stop smoking, incidence rates will remain unchanged" report to their offering.

“Epidemiology: Non-Small Cell Lung Cancer - Despite global efforts to stop smoking, incidence rates will remain unchanged”

Smoking is the leading cause of lung cancer, responsible for 95% of all cases. Global efforts to stop smoking have stabilized over the last decade. Epidemiologists expect the number of total incident cases of non-small cell lung carcinoma to remain stable in the seven major markets over the next 10 years.

Features and benefits of this report:

• Gain insight into market potential, including a robust 10-year epidemiology forecast of non-small cell lung cancer.
• Understand the key epidemiologic risk factors associated with non-small cell lung cancer.

Highlights:

• Most people are not diagnosed with lung cancer until the disease has advanced to later-stage illness, making it difficult to treat the cancer successfully and greatly impacting 5-year survival rates for the disease. Smoking cessation is the most effective measure in reducing the risk of non-small cell lung cancer.
• For newly diagnosed non-small cell lung cancer in the seven major markets, adults aged 70-74 will have the largest number of total incident cases (80,310 cases), followed by adults ages 65-69 and 75-79 (73,500 cases and 71,300 cases, respectively).

Your key questions answered:

• What are the most robust sources for non-small cell lung cancer incidence data?
• How will the patient population change through to 2020 in the US, Japan, and the five major EU markets (France, Germany, Italy, Spain, and the UK)?
• How do changes in population structure and risk factors affect the trend in incident non-small cell lung cancer cases?

For more information visit http://www.researchandmarkets.com/research/ea4043/epidemiology_non

Source: Datamonitor